Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 29, 2025, Agile Therapeutics (AGRX) has a market cap of $10.426 million USD. According to our data, Agile Therapeutics is ranked No.8807 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Aug 26, 2024 | $10.43 M |
-22.56%
|
| Dec 29, 2023 | $13.46 M |
-82.82%
|
| Dec 30, 2022 | $78.37 M |
-98.84%
|
| Dec 31, 2021 | $6.74 B |
-82.99%
|
| Dec 31, 2020 | $39.63 B |
14.80%
|
| Dec 31, 2019 | $34.52 B |
334.10%
|
| Dec 31, 2018 | $7.95 B |
-78.59%
|
| Dec 29, 2017 | $37.15 B |
-52.81%
|
| Dec 30, 2016 | $78.71 B |
-41.60%
|
| Dec 31, 2015 | $134.78 B |
58.96%
|
| Dec 31, 2014 | $84.79 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 TherapeuticsMD
TXMD
|
$14.24 M |
0.000 M
|
USA
|
 Evofem Biosciences
EVFM
|
$0.99 M |
0.000 M
|
USA
|
 Agile Therapeutics
AGRX
|
$10.43 M |
0.000 M
|
USA
|
 Amgen
AMGN
|
$152.20 B |
0.126 B
|
USA
|
 Pfizer
PFE
|
$130.73 B |
-0.001 M
|
USA
|
 Merck
MRK
|
$212.01 B |
-0.001 M
|
USA
|
 Teva Pharmaceutical Industries
TEVA
|
$18.23 B |
0.362 B
|
Israel
|
 Johnson & Johnson
JNJ
|
$375.13 B |
0.006 M
|
USA
|
 AbbVie
ABBV
|
$342.32 B |
-0.001 M
|
USA
|
 Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
USA
|
 Eli Lilly
LLY
|
$794.90 B |
-0.026 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$98.62 B |
0.002 M
|
USA
|
 GlaxoSmithKline
GSK
|
$77.05 B |
0.003 M
|
UK
|
 Novartis
NVS
|
$224.23 B |
0.160 B
|
Switzerland
|
| Market Cap | = | AGRX Stock Price | * | AGRX Shares Outstanding |
| = | $1.51 | * | 6.90 M | |
| = | $10.43 M |